lenalidomide grindeks 15mg tvrdá tobolka
as grindeks, riga array - 3207 lenalidomid s chloridem amonnÝm - tvrdá tobolka - 15mg - lenalidomid
lenalidomide grindeks 20mg tvrdá tobolka
as grindeks, riga array - 3207 lenalidomid s chloridem amonnÝm - tvrdá tobolka - 20mg - lenalidomid
lenalidomide grindeks 2,5mg tvrdá tobolka
as grindeks, riga array - 3207 lenalidomid s chloridem amonnÝm - tvrdá tobolka - 2,5mg - lenalidomid
lenalidomide grindeks 25mg tvrdá tobolka
as grindeks, riga array - 3207 lenalidomid s chloridem amonnÝm - tvrdá tobolka - 25mg - lenalidomid
lenalidomide grindeks 5mg tvrdá tobolka
as grindeks, riga array - 3207 lenalidomid s chloridem amonnÝm - tvrdá tobolka - 5mg - lenalidomid
lenalidomide grindeks 7,5mg tvrdá tobolka
as grindeks, riga array - 3207 lenalidomid s chloridem amonnÝm - tvrdá tobolka - 7,5mg - lenalidomid
jaxteran 120mg enterosolventní tvrdá tobolka
zentiva, k.s., praha array - 19947 dimethyl-fumarÁt - enterosolventní tvrdá tobolka - 120mg - dimethyl-fumarÁt
jaxteran 240mg enterosolventní tvrdá tobolka
zentiva, k.s., praha array - 19947 dimethyl-fumarÁt - enterosolventní tvrdá tobolka - 240mg - dimethyl-fumarÁt
calquence
astrazeneca ab - acalabrutinib - leukémie, lymfocytární, chronická, b-buňka - antineoplastic agents, protein kinase inhibitors, - calquence as monotherapy or in combination with obinutuzumab is indicated for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (cll). calquence as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukaemia (cll) who have received at least one prior therapy.
arbicen 120mg enterosolventní tvrdá tobolka
egis pharmaceuticals plc, budapešť array - 19947 dimethyl-fumarÁt - enterosolventní tvrdá tobolka - 120mg - dimethyl-fumarÁt